NFE2L2 and cancer: Another study also displayed that brusatol exerts effective growth-inhibitory activity against HER2-positive cancer cells by inhibiting the Nrf2/HO-1 antioxidant pathway and the HER2/AKT/ERK1/2 signaling pathway.